Chinese Journal of Cancer Research

, Volume 2, Issue 2, pp 28–30 | Cite as

The alternative pathaway of human T cell activation by monoclonal antibodies

A comparative study between normal individuals and cancer patients
  • Chen Yuxian
  • Xia Hanzhang
  • Zhang Xiaoying
  • Li Yanfen
  • Chen Feng
  • Shi Wei
  • Xu Bingze
  • Huang Yirong
  • Zhang Youhui
Basic Investigations
  • 9 Downloads

Abstract

This paper described T cell proliferative response by an alternative pathway in normal subjects and in patients with malignant diseases. Two McAbs, Anti-CCT1 and Lo-CD2-act recognizing two distinct epitopes on E-receptor (CD2) were used to costimulate PBMC. Proliferative responsiveness was measured by3H-thymidine incorporation. It was found that 82% of 72 normal subjects gave proliferative response whereas only 23% of the 93 patients did. The average cpm±SD in patients with bladder cancer (118±2314), kidney cancer (1619±2719) or lymphoma (2518±4057) was significantly lower than that in normal subjects (4935±2314), (P<0.001). These results indicate that T cell proliferation through the alternative pathway was significantly depressed in patients with cancer, and this can be used as a new parameter to monitor the immune status of cancer patients.

Keywords

Bladder Cancer Alternative Pathway Proliferative Response Kidney Cancer Sheep Erythrocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Martin PJ, et al. Identification and functional characterization of two distinct epitopes on human T cell surface protein. J Immunol 1983; 131:180.PubMedGoogle Scholar
  2. 2.
    Meuer SC, et al. An alternative pathway of T cell activation: A function role for the 50kD T11 sheep erythrocyte receptor protein. Cell 1984; 36:897.PubMedCrossRefGoogle Scholar
  3. 3.
    Huet S, et al. T cell activation via CD2 (T. tivating resting T cells via CD2. J Immunol 1986; 137:1420.PubMedGoogle Scholar
  4. 4.
    Olive D, et al. Pairs of anti-T11.1 and T11.2 are strongly mitogenic for T cells in presence of TPA. Eur J Immunol 1986; 16:1063.PubMedCrossRefGoogle Scholar
  5. 5.
    1986; 6:65.Google Scholar
  6. 6.
    1987; 7:159.Google Scholar
  7. 7.
    1987; 3:2.Google Scholar
  8. 8.
    Wallner BP, et al. Primary structure of lymphocyte function associated antigen 3 (LFA-8): The ligand of the T lymphocyte CD2 glycoprotein. J Exp Med 1987; 166:923.PubMedCrossRefGoogle Scholar

Copyright information

© Chinese Journal Of Cancer Research 1990

Authors and Affiliations

  • Chen Yuxian
    • 1
  • Xia Hanzhang
    • 1
  • Zhang Xiaoying
    • 1
  • Li Yanfen
    • 1
  • Chen Feng
    • 1
  • Shi Wei
    • 1
  • Xu Bingze
    • 1
  • Huang Yirong
    • 1
  • Zhang Youhui
    • 1
  1. 1.Cancer InstituteChinese Academy of Medical SciencesBeijing

Personalised recommendations